Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02792270 · ClinicalTrials.gov registry record · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
A NA study of Tumor Surgery, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT02792270: Recruiting NA study of Tumor Surgery, sponsored by Massachusetts General Hospital.
NCT02792270 is a NA study of Tumor Surgery that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02792270, a NA study of Tumor Surgery, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to decrease the rate of surgical wound complications. The investigators are studying the effects that caloric restriction has on decreasing the rate of surgical wound complications.
Primary Outcome
The Musculoskeletal Tumor Society Rating Scale (MSTS) is a clinician-based scoring system that is scored out of 35 points. A higher score indicates better physical function.
Conditions Studied
Interventions
- OTHER Caloric Restriction Diet
Study Locations (1)
Massachusetts
- Massachusetts general Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-06 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT02792270 shows while recruiting
NCT02792270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Tumor Surgery appearing as the primary indexed condition, and to 1 intervention - of which Caloric Restriction Diet is the first listed.
NCT02792270 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02792270 about?
NCT02792270 is a clinical study titled "Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT". This study is being conducted to decrease the rate of surgical wound complications. The investigators are studying the effects that caloric restriction has on decreasing the rate of surgical wound complications.
What is the current status of trial NCT02792270?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2016-06. Estimated completion is 2027-05.
What conditions does trial NCT02792270 study?
This clinical trial studies the following conditions: Tumor Surgery.
What interventions are being tested in trial NCT02792270?
The interventions under investigation include: Caloric Restriction Diet (OTHER).
Who is sponsoring clinical trial NCT02792270?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02792270 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02792270's enrollment target sits among peer trials
32 1579th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
- NCT03530852 · 32 participants · NA
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia